C13H15N3O5
Neat
293.28
Room Temperature
1485081-26-2; UNII-FL5H7DIENP; M1 of dolutegravir; FL5H7DIENP; 2H-Pyrido(1', 2':4, 5)pyrazino(2, 1-beta)(1, 3)oxazine-9-carboxamide, 3, 4, 6, 8, 12, 12alpha-hexahydro-7-hydroxy-4-methyl-6, 8-dioxo-, (4R, 12alphaS)-; 2H-PYRIDO(1', 2':4, 5)PYRAZINO(2, 1-.BETA.)(1, 3)OXAZINE-9-CARBOXAMIDE, 3, 4, 6, 8, 12, 12.ALPHA.-HEXAHYDRO-7-HYDROXY-4-METHYL-6, 8-DIOXO-, (4R, 12.ALPHA.S)-; RefChem:201544; Dolutegravir impurity E; Dolutegravir M1; (3S, 7R)-11-hydroxy-7-methyl-9, 12-dioxo-4-oxa-1, 8-diazatricyclo[8.4.0.03, 8]tetradeca-10, 13-diene-13-carboxamide; N-De-2, 4-difluorobenzyl Dolutegravir; orb1693440; CHEMBL3526572; SCHEMBL17694739; AKOS040755462; HY-W749636; N-De-2, 4-difluorobenzyl Dolutegravir; 2H-Pyrido[1', 2':4, 5]pyrazino[2, 1-b][1, 3]oxazine-9-carboxamide, 3, 4, 6, 8, 12, 12a-hexahydro-7-hydroxy-4-methyl-6, 8-dioxo-, (4R, 12aS)- (ACI); (4R, 12aS)-3, 4, 6, 8, 12, 12a-Hexahydro-7-hydroxy-4-methyl-6, 8-dioxo-2H-pyrido[1', 2':4, 5]pyrazino[2, 1-b][1 and 3]oxazine-9-carb
(3S, 7R)-11-hydroxy-7-methyl-9, 12-dioxo-4-oxa-1, 8-diazatricyclo[8.4.0.03, 8]tetradeca-10 and 13-diene-13-carboxamide
InChI=1S/C13H15N3O5/c1-6-2-3-21-8-5-15-4-7(12(14)19)10(17)11(18)9(15)13(20)16(6)8/h4,6,8,18H,2-3,5H2,1H3,(H2,14,19)/t6-,8+/m1/s1